FDA Grants Orphan Drug Status To Two New Therapies In a Row, And These Two Groups Of Patients Are Expected To Benefit!

For Fatal Rhabdomyosarcoma, New Atr Inhibitors May Hold Therapeutic Promise

Cedars-Sinai Medical Center

US National Children's Hospital

Innovative Therapy Zolbetuximab In Combination With Chemotherapy Significantly Improves Survival Of Gastric Cancer Patients!

University Of Washington Medical Center